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Abstract
Crimean-Congo hemorrhagic fever and dengue hemorrhagic fever are endemic in Pakistan. However, the overlap of geographic distribution
and early clinical features between the two conditions make a reliable diagnosis difficult in the initial stage of illness. A 16-year-old boy
presented with a history of hematemesis and high-grade fever. A preliminary diagnosis of dengue hemorrhagic fever was made and
supportive treatment was instituted; however, the patient continued to deteriorate clinically. Dengue IgM antibody testing was negative on
the third day of admission. Qualitative polymerase chain reaction test for Crimean-Congo hemorrhagic fever viral RNA was sent but the
patient expired shortly after the results became available on the sixth day of admission. Considerable resources had to be expended on contact
tracing and administration of ribavirin prophylaxis to all the health-care workers who had come in contact with the patient. It is crucial that
Crimean-Congo hemorrhagic fever be recognized and treated at an early stage because of longer term financial and health implications for
contacts such as health-care workers in the setting of a developing country. Increased surveillance of dengue and Crimean-Congo
hemorrhagic fever cases is warranted for the derivation of reasonably reliable, cost-effective and prompt predictors of disease diagnosis.
These predictors can help guide future decisions in the management of similar cases. Ultimately, such a strategy may translate into better cost
containment in resource-poor settings. Institution of ribavirin prophylaxis in selected patients also merits consideration.
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Introduction
Crimean-Congo Hemorrhagic Fever (CCHF)
virus (genus Nairovirus, family Bunyaviridae) is an
enveloped virus with a genome consisting of three
segments of single-stranded RNA of negative
polarity [1]. This zoonotic virus is transmitted either
through bite of the tick vector, mainly Hyalomma
spp., or via direct contact with blood or tissues of
viremic animals or humans [2]. The infection
typically affects the reticuloendothelial system and
causes activation of cytokine cascades in the body.
This, in turn, leads to increased vascular permeability
in the victims, ultimately culminating in hemorrhage
and shock. As the disease evolves, multiple organ
systems such as hematopoietic, neurologic, and
pulmonary systems become involved [3,4].
On the other hand, dengue virus belongs to the
Flavivirus family and is transmitted through the bite
of Aedes mosquitoes. The virus has four distinct
serotypes. A person infected by one serotype

develops life-long immunity to that particular
serotype; however, infection by any of the other three
seroptypes will have devastating consequences for
that individual due to the phenomenon of “antibody
enhancement” [5,6]. Dengue virus infection can
manifest along a wide clinical spectrum including
dengue fever (DF), dengue hemorrhagic fever (DHF)
and dengue shock syndrome (DSS). DF patients
present with fever, myalgias and morbilliform rash.
In DHF, patients additionally have hemorrhagic
manifestations while DSS patients have circulatory
failure as a predominant feature [6]. The underlying
pathophysiologic basis for the signs and symptoms of
DHF and DSS is an increase in the permeability of
the vasculature [5].
CCHF was first reported in the Crimea, Russia in
1944 [7]. Since then outbreaks have been described
from various regions of the Middle East as well as
Pakistan [8]. CCHF is endemic in Pakistan and
multiple healthcare associated outbreaks have also
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been reported since the detection of the first case in
1976 [8]. Although outbreaks of CCHF in Pakistan
have classically occurred in rural Balochistan, CCHF
cases have also occurred in Karachi in recent times
[1]. CCHF cases in Pakistan have mainly occurred in
the months of October and November [1]. This time
period roughly corresponds to the Islamic festival of
Eid-ul-Azha, celebrated on days 10 to 13 of the last
month of each lunar calendar year, when large flocks
of sacrificial animals are brought into the cities from
the rural areas of Pakistan [4].
DHF was first recognized in Asia in the 1950s
[9]. The first major outbreak of DF in Karachi
occurred in 1994 [5]. Since then this cosmopolitan
city has experienced a few outbreaks of this arboviral
fever, the most recent of which occurred in 2005–
2006. During this epidemic, heavy morbidity and
mortality burden was reported [10,11]. The case
fatality rate incurred from CCHF has been reported to
be considerably higher (15 – 100%) as compared to
DF (the case fatality rate for dengue shock syndrome
and dengue hemorrhagic fever is around 3% – 5 % in
Pakistan) [8,12-15].
The overlap of the geographic distribution and
the similarity of the initial presentation of DF and
CCHF make it difficult to reliably differentiate the
two conditions, especially in the initial stages of the
illness. Although conclusive, laboratory tests,
particularly molecular-based tests, are not
ubiquitously available in Pakistan. Such tests are also
expensive and require time for completion. Patients,
therefore, must be managed initially on clinical
suspicion alone until laboratory results become
available. However, this approach may sometimes
have important subsequent implications when a
definitive diagnosis becomes available. We describe
here a case of CCHF in a young male who was
initially managed on the suspicion of DHF.
Considerable resources had to be expended later
when a diagnosis of CCHF was confirmed in the
same patient.
Case history
A 16-year-old male presented to the emergency
department of Aga Khan University Hospital
(AKUH) with a recent history of three episodes of
large quantity hematemesis. He had also had
intermittent, high-grade fever with chills and rigors
for five days prior to presentation and multiple
episodes of non-bilious vomiting and watery
diarrhoea for two days. The remaining history
obtained from the patient was unremarkable for tick
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bites, contact with animals, persons with similar
illness, and recent or remote travel. He was a resident
of Karachi, Pakistan.
At admission, he was febrile (38.3°C) and
moderately dehydrated. He was otherwise
hemodynamically stable at that time. Physical
examination did not reveal any cutaneous rash or
active source of bleeding from mucocutaneous
surfaces. Remaining general and systemic
examinations were also unremarkable. Emergent
management of the patient included fluid
resuscitation and nasogastric (NG) tube placement.
The aspirate from the tube revealed a large quantity
of blood. Laboratory values at this time showed
thrombocytopenia (10 x 109/L), leucopenia (2 x
109/L), raised serum creatinine (1.5 mg/dl), and
raised international normalized ratio (1.5) (Figure 1).
A preliminary diagnosis of DHF was made and the
patient was admitted into the special care unit (SCU).
Fluid resuscitation continued and the initial
management plan consisting of platelet transfusions
and broad spectrum antibiotics was followed.
During the first three days of admission, the
patient’s vital signs deteriorated, particularly his
blood pressure and pulse. In addition, his Glasgow
coma scale (GCS) scores dropped dramatically. He
was therefore intubated and transferred to the
intensive care unit (ICU). His chest roentgenogram
showed bilateral perihilar edema. He developed
oliguria and his serum creatinine also showed serial
increments. Dengue IgM antibody, which had been
sent to the laboratory on the first day of admission,
came back negative on the third day of admission.
Elevated fibrin degradation products (18 mg/l) and
D-dimer values (3.74 units) indicated development of
consumption coagulopathy. Qualitative PCR for
CCHF viral RNA was sent at this time in view of the
patient’s rapidly deteriorating clinical status and
negative dengue serology.
Over the next few days, multi-organ failure
developed rapidly and he was placed on continuous
renal replacement therapy (CRRT). He also had an
episode of atrial fibrillation with rapid ventricular
rate (190-210 beats/min) requiring synchronized
cardioversion on the sixth day of admission. PCR for
CCHF viral RNA returned positive at this time.
Before any specific measures could be instituted after
the receipt of this result, the patient became
bradycardiac and developed pulseless electrical
activity (PEA). Cardiopulmonary resuscitation (CPR)
code was initiated; however, it was stopped after 28
minutes of continuous resuscitative efforts.
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Figure 1. Serial measurements of the platelets and INR values of the patient during his hospital stay (a single value represents the
average measurement of that parameter over 24 hours). Primary vertical axis shows INR values while the secondary vertical axis shows
platelet count. Day 1 corresponds to the day of admission to the hospital.

A meeting of the health-care team with the
patient’s family was immediately arranged. On
directed questioning, they revealed that although two
other members of the patient’s family had
experienced mild upper respiratory tract symptoms a
few days ago, they had recovered uneventfully and
did not have any current health complaints. They
were counselled to visit the hospital in case any other
family member developed symptoms.
Contact tracing of individuals in the hospital was
also done. Seven doctors and 18 nurses were
identified and given ribavirin prophylaxis for seven
days. The total cost of this course for these
individuals was US $401. Some of these health-care
professionals also reported adverse effects from the
prophylactic treatment, including jaundice, nausea,
and hair loss.
As soon as the patient had been identified as a
case of CCHF, he was put in strict isolation per
CCHF policy developed on the basis of the Centers
for Disease Control and Prevention (CDC)
recommendations. Prior to this, we were following
only standard precautions. After the patient died, his
body was bathed by the nursing staff, who ensured
strict isolation in addition to contact and respiratory
precautions. The cadaver was then carefully wrapped
in a leak-proof bag. The family was also counselled
about the hazards of bathing or exposing the body
any further. They were advised to bury the body
within the sealed bag.

Discussion
Infectious diseases still play a significant role in
shaping the morbidity and mortality patterns in the
developing countries [2]. Physicians in these areas
stand at crossroads because of the endemic nature
and non-specific overlapping features of many
infectious diseases, such as tuberculosis, malaria,
typhoid, and viral fevers. In Pakistan, viral
hemorrhagic fevers (VHFs) such as CCHF are
increasingly recognized as a public health problem
with immense implications for the already limited
health-care resources [2]. It is unfortunate that the
understanding regarding clinical presentations and
modes of spread of CCHF among health-care
personnel in Pakistan is poor despite the endemic
nature of the condition [16]. Similarly, knowledge
about the basic principles of infection control among
health-care personnel and hospital administrators is
lacking [2]. Education of both the public as well as
health-care professionals about viral hemorrhagic
fevers should, therefore, be undertaken on an urgent
footing.
The delay in reaching a diagnosis of CCHF may
be due to the prudence of ruling out competing and
commoner diagnoses as well as the reliance on
effective laboratory testing in such cases. In addition,
media has preferentially highlighted DF as an
emerging health problem when compared to CCHF.
As mentioned earlier, CCHF cases in Pakistan have
been increasingly documented around the time of the
Islamic festival of Eid-ul-Azha in recent years. This
461
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is possibly due to the large flocks of sacrificial
animals that are brought into the cities from the rural
areas of Pakistan. The animals are kept in open areas
or private enclosures and are usually slaughtered
within the first three days of this Islamic festival [4].
Although no formal study has been conducted to
investigate the burden or presence of Hyalomma ticks
in Karachi, such a study is certainly warranted in
view of the increasing number of cases of CCHF
being reported from the city. It is possible that CCHF
in this particular case was not suspected initially
because of lack of this temporal association. In
addition, history of exposure to livestock or other
animals and infected individuals may not always be
readily available from patients [1]. This patient did
not give any history of exposure to livestock or ticks
and examination also did not reveal any tick bites.
All these factors can compositely delay the diagnosis
and do not bode well for a resource-poor country
such as Pakistan as far as cost-containment is
concerned.
There are considerable overlaps in the clinical
presentations of both CCHF and DHF. Patients with
CCHF and DHF are both young (mean age for both
has been reported to be approximately 26 years).
Both diseases occur more frequently in males
[1,14,15]. CCHF cases are frequently encountered in
the months of October and November in Pakistan. In
comparison, DHF cases have been reported in the
months of August, September and October [1,15].
This temporal distribution for CCHF has been
explained on the basis of increased livestock
movement into cities at the time of Eid-ul-Azha [4].
For DHF, the temporal association of these months to
illness can be explained by the rains of the monsoon
season in Pakistan in July and August every year,
when pools of stagnant water serve as important
breeding hubs for the Aedes mosquitoes [15].
Patients with CCHF generally present with fever,
vomiting and bleeding from body orifices (≥ 50% of
cases); however, petechiae or echymoses are seen
less commonly (~30%) [1,4]. In comparison, patients
with DHF present with chills/rigors, vomiting,
diarrhoea, headaches and abdominal pain [5,6,14].
Up to 35% patients with DHF present with mucosal
bleeding while a morbiliform rash is present in about
80% of patients [5]. Skin lesions seen in DF are
usually generalized macular blanchable erythematous
rash (65%) followed by discrete petechial lesions
(35%) and palmar erythema (30%) [17]. However,
other studies from Pakistan have reported a lower
incidence of skin rash (24%) in patients with DHF.
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The discrepancy has been explained on the basis of
factors that make detection of the rash difficult, such
as a short-lived course of the rash, lack of itching,
and the dark skin of the local population [6].
Although this particular patient presented with
hematemesis and no rash, a diagnosis of DHF was
made initially on the basis of a negative history for
tick bites and exposure to livestock.
Laboratory parameters in patients with DHF and
CCHF are also generally non-specific as patients with
both diseases demonstrate thrombocytopenia,
leucopenia with lymphocytosis, deranged coagulation
profiles, deranged liver function tests, and elevated
serum creatinine [1,4,5,13,15]. Although patients
with CCHF are more likely to have persistent
thrombocytopenia [1] as compared to patients with
DHF who experience a nadir in platelet count during
hospital stay followed by improvement [6], this
phenomenon needs to be investigated in future
studies.
Although we did not administer ribavirin in this
patient, one possible strategy to consider in the future
is the institution of ribavirin prophylaxis in selected
patients. The diagnosis of CCHF is usually dependant
on laboratory evaluation that is not available until
after a few days of admission. Ribavirin should be
given to such selected patients in whom a diagnosis
of CCHF is strongly suspected on the basis of clinical
grounds alone or whose clinical features sufficiently
overlap features with DHF and in whom dengue
serology is inconclusive. This approach may help
prevent mortalities in cases similar to ours in the
future.
Conclusion
In summary, our case represents a complex
clinical scenario whereby the patient was initially
suspected of having DHF, a disease that does not
require institution of specific measures such as
contact isolation or use of oral anti-viral agents.
However, the diagnosis of CCHF was established on
the sixth day of admission. Although the patient died
shortly thereafter, considerable resources were spent
on not only tracking contacts who had been exposed
by this time but also on administering post-exposure
prophylaxis to such contacts. The diversion of
hospital resources towards these measures represents
a considerable degree of necessary disruption
undertaken to prevent spread of the disease. Also,
CCHF cases may generate considerable stress and
fear among hospital staff and other contacts [12].
Previously, CCHF related deaths in health-care
462
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workers have been reported from Pakistan on a few
occasions [1,8,18].
It is vital for clinicians to recognize CCHF at an
early stage. However, that is not always possible..
Improved education of health-care workers and
improved surveillance of DF and CCHF should be
ensured in our region so that we can devise
reasonably reliable, cost-effective and prompt
predictors of disease diagnosis on the basis of the
collected data. As this case clearly demonstrates, one
of the biggest challenges we face in the early
recognition of CCHF is our location in a dengueendemic area.
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